To identify molecular changes that occur during prostate
tumor progression, we have characterized a series of
prostate cancer cell lines isolated at different stages of
tumorigenesis from C3(1)/Tag transgenic mice. Cell lines derived from low- and high-grade
prostatic intraepithelial neoplasia, invasive
carcinoma, and a lung
metastasis exhibited significant differences in cell growth, tumorigenicity, invasiveness, and angiogenesis.
cDNA microarray analysis of 8700 features revealed correlations between the tumorigenicity of the C3(1)/Tag-Pr cells and changes in the expression levels of genes regulating cell growth, angiogenesis, and invasion. Many changes observed in transcriptional regulation in this in vitro system are similar to those reported for human
prostate cancer, as well as other types of human
tumors. This analysis of expression patterns has also identified novel genes that may be involved in mechanisms of prostate
oncogenesis or serve as potential
biomarkers or therapeutic targets for
prostate cancer. Examples include the L1-cell adhesion molecule,
metastasis-associated gene (MTA-2), Rab-25,
tumor-associated signal transducer-2 (Trop-2), and
Selenoprotein-P, a gene that binds
selenium and prevents oxidative stress. Many genes identified in the Pr-cell line model have been shown to be altered in human
prostate cancer. The comprehensive microarray data provides a rational basis for using this model system for studies where alterations of specific genes or pathways are of particular interest. Quantitative real-time reverse transcription-PCR for
Selenoprotein-P demonstrated a similar down-regulation of the transcript of this gene in a subset of human prostate
tumors, mouse
tumors, and prostate
carcinoma cell lines. This work demonstrates that expression profiling in animal models may lead to the identification of novel genes involved in human
prostate cancer biology.